Sign up to save your podcasts
Or
Share EU orders Illumina to divest Grail after 'unlawful' merger
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
EU orders Illumina to divest Grail after 'unlawful' merger
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, October 13, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Orthofix launched its OsteoCove bioactive synthetic graft. Fast Five hosts Danielle Kirsh and Jim Hammerand discuss the features of the device and what executives are thinking about the launch.
Medtronic won CE mark approval for its Evolut FX TAVI. Hear what doctors think about the device and what makes it unique compared to other devices in the Evolut portfolio.
Getinge is making an infection prevention play with its latest acquisition of Healthmark. Get the financial details of the detail and how it will help Getinge's business in the long run.
A judge has granted preliminary approval to Philips' class action settlement. Kirsh and Hammerand talk about the financials behind the settlement and what lawyers are saying.
The EU has ordered Illumina to divest and unwind its merger with Grail. Listen to today's episode to hear about what the EU ordered and why the European Commission came to that decision.
View all episodes
By MassDeviceWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, October 13, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Orthofix launched its OsteoCove bioactive synthetic graft. Fast Five hosts Danielle Kirsh and Jim Hammerand discuss the features of the device and what executives are thinking about the launch.
Medtronic won CE mark approval for its Evolut FX TAVI. Hear what doctors think about the device and what makes it unique compared to other devices in the Evolut portfolio.
Getinge is making an infection prevention play with its latest acquisition of Healthmark. Get the financial details of the detail and how it will help Getinge's business in the long run.
A judge has granted preliminary approval to Philips' class action settlement. Kirsh and Hammerand talk about the financials behind the settlement and what lawyers are saying.
The EU has ordered Illumina to divest and unwind its merger with Grail. Listen to today's episode to hear about what the EU ordered and why the European Commission came to that decision.